Skip to main content

Table 1 Patients’ characteristics

From: IL32 expression in peripheral blood CD3+ cells from myelodysplastic syndromes patients

Patients

Number

MDS

39

 Gender

  Male/Female

18/21

Age (years), median (range):

69 (27–89)

 WHO classification

 

  RA/RARS/RCMD

04/07/20

  RAEB-1/RAEB-2

07/01

Cytogenetic riska

 Very good/good

01/32

 Intermediate

02

 Poor/very poor

01/01

 No growth

02

  1. Abbreviations: MDS myelodysplastic syndromes, WHO World Health Organization, RA refractory anemia, RARS refractory anemia with ringed sideroblasts, RCMD refractory cytopenia with multilineage dysplasia, RAEB-1 refractory anemia with excess blast-1, RAEB-2 refractory anemia with excess blast-2, BM bone marrow. aIn MDS cohort, karyotype findings included very good : –Y (n = 1); good: normal (n = 32), intermediate: +8 (n = 1); other (n = 1); poor: 3 abnormalities (n = 1), and very poor: >3 abnormalities (n = 1)